Skip to main content
Erschienen in:

18.10.2020 | Editorial

The imperative to assess physical function among all patients undergoing stress myocardial perfusion imaging

verfasst von: Alan Rozanski, MD, Daniel S. Berman, MD, Ami E. Iskandrian, MD, MASNC

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Auszug

Stress rest myocardial perfusion imaging (MPI) can be performed using either single-photon emission computed tomography (SPECT) or positron emission tomography (PET). However, PET imaging offers important advantages, including higher spatial resolution and shorter imaging protocols due to the higher photon sensitivity of PET scanners and more rapid clearance of PET radiotracers from the background, and the routine use of attenuation correction. In addition, PET-MPI allows for the absolute quantification of myocardial blood flow and assessment of coronary flow reserve. But unlike SPECT-MPI, PET-MPI is not performed in conjunction with exercise testing due to the limitations poised by current PET radiotracers. 82Rubidium, the most commonly used PET-MPI radiotracer, has a half-life of only 76 seconds. Thus, its use mandates that patients be in the PET scanner at the time of stress imaging, performed using vasodilator agents such as adenosine or regadenoson. By using 13N-ammonia with its half-life of 9.8 minutes, it is possible to use it in conjunction with exercise testing.1,2 However, exercise PET with 13N-ammonia is uncommonly performed because until now, this tracer has required an on-site cyclotron for its production and use. To-date, such on-site cyclotrons have been limited to a very small percentage of clinical imaging centers. …
Literatur
1.
Zurück zum Zitat Aggarwal NR, Drozdova A, Askew JW 3rd, Kemp BJ, Chareonthaitawee P (2015) Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol 22:1273-1280CrossRef Aggarwal NR, Drozdova A, Askew JW 3rd, Kemp BJ, Chareonthaitawee P (2015) Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol 22:1273-1280CrossRef
2.
Zurück zum Zitat Chow BJ, Beanlands RS, Lee A et al (2006) Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Cardiol 47:411-416CrossRef Chow BJ, Beanlands RS, Lee A et al (2006) Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Cardiol 47:411-416CrossRef
3.
Zurück zum Zitat Harlan DR, Galazka PZ, Muhlum D, Falk J, Port SC (2015) Feasibility of exercise treadmill 13N-ammonnia positron emission tomography myocardial perfusion imaging using an off-site cyclotron. J Nucl Cardiol 22:1273CrossRef Harlan DR, Galazka PZ, Muhlum D, Falk J, Port SC (2015) Feasibility of exercise treadmill 13N-ammonnia positron emission tomography myocardial perfusion imaging using an off-site cyclotron. J Nucl Cardiol 22:1273CrossRef
4.
Zurück zum Zitat Master AM, Oppenheimer ET (1929) A simple tolerance test for circulatory efficiency with standard tables for normal individuals. Am J Med Sci 177:223-242CrossRef Master AM, Oppenheimer ET (1929) A simple tolerance test for circulatory efficiency with standard tables for normal individuals. Am J Med Sci 177:223-242CrossRef
5.
Zurück zum Zitat Master AM, Friedman R, Dack S (1942) The electrocardiogram after standard exercise as a functional test of the heart. Am Heart J 77:777-793CrossRef Master AM, Friedman R, Dack S (1942) The electrocardiogram after standard exercise as a functional test of the heart. Am Heart J 77:777-793CrossRef
6.
Zurück zum Zitat Bruce RA, Blackmon JR, Jones JW, Strait G (1963) Exercise testing in adult subjects and cardiac patients. Pediatrics 32:742-756CrossRef Bruce RA, Blackmon JR, Jones JW, Strait G (1963) Exercise testing in adult subjects and cardiac patients. Pediatrics 32:742-756CrossRef
7.
Zurück zum Zitat Mcneer JF, Margolis JR, Lee KL (1978) The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 57:64-67CrossRef Mcneer JF, Margolis JR, Lee KL (1978) The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 57:64-67CrossRef
8.
Zurück zum Zitat Ladenheim ML, Pollack BH, Rozanski A et al (1986) Extent and severity of myocardial hypoperfusion as orthogonal indices of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7:464-471CrossRef Ladenheim ML, Pollack BH, Rozanski A et al (1986) Extent and severity of myocardial hypoperfusion as orthogonal indices of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7:464-471CrossRef
9.
Zurück zum Zitat Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleishchmann KE (2007) The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography. J Am Coll Cardiol 49:227-237CrossRef Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleishchmann KE (2007) The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography. J Am Coll Cardiol 49:227-237CrossRef
10.
Zurück zum Zitat Iskander S, Iskandrian AE (1998) Risk assessment using single-photon emission computed tomographic technetium99m sestamibi imaging. J Am Coll Cardiol 32:57-62CrossRef Iskander S, Iskandrian AE (1998) Risk assessment using single-photon emission computed tomographic technetium99m sestamibi imaging. J Am Coll Cardiol 32:57-62CrossRef
11.
Zurück zum Zitat Bairey Merz CN, Rozanski A, Maddahi A, Resser KJ, Berman DS (1989) Exercise thallium-201 scintigraphy and prognosis in patients with typical angina and negative exercise electrocardiography. Am J Cardiol 64:282-288CrossRef Bairey Merz CN, Rozanski A, Maddahi A, Resser KJ, Berman DS (1989) Exercise thallium-201 scintigraphy and prognosis in patients with typical angina and negative exercise electrocardiography. Am J Cardiol 64:282-288CrossRef
12.
Zurück zum Zitat Rozanski A, Gransar H, Hayes SW et al (2013) Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 61:1054-1065CrossRef Rozanski A, Gransar H, Hayes SW et al (2013) Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 61:1054-1065CrossRef
13.
Zurück zum Zitat Ma J, Ward EM, Siegel RL, Jemal A (2015) Temporal trends in mortality in the United States, 1969–2013. JAMA 314:1731-1739CrossRef Ma J, Ward EM, Siegel RL, Jemal A (2015) Temporal trends in mortality in the United States, 1969–2013. JAMA 314:1731-1739CrossRef
14.
Zurück zum Zitat Rozanski A, Gransar H, Min JK et al (2014) Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol 21:341-350CrossRef Rozanski A, Gransar H, Min JK et al (2014) Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol 21:341-350CrossRef
15.
Zurück zum Zitat Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV (2004) Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 11:551-561CrossRef Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV (2004) Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 11:551-561CrossRef
16.
Zurück zum Zitat Rozanski A, Gransar H, Hayes SW, Friedman JD, Hachamovitch R, Berman DS (2010) Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. J Nucl Cardiol 17:999-1008CrossRef Rozanski A, Gransar H, Hayes SW, Friedman JD, Hachamovitch R, Berman DS (2010) Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. J Nucl Cardiol 17:999-1008CrossRef
17.
Zurück zum Zitat Johnson NP, Schimmel DR, Dyer SP, Leonard SM, Holly TA (2011) Survival by stress modality in patients with a normal myocardial perfusion study. Am J Cardiol 107:986-989CrossRef Johnson NP, Schimmel DR, Dyer SP, Leonard SM, Holly TA (2011) Survival by stress modality in patients with a normal myocardial perfusion study. Am J Cardiol 107:986-989CrossRef
18.
Zurück zum Zitat Supariwala A, Uretsky S, Depuey EG et al (2013) Influence of mode of stress and coronary risk factor burden upon long-term mortality following normal stress myocardial perfusion single-photon emission computed tomographic imaging. Am J Cardiol 111:846-850CrossRef Supariwala A, Uretsky S, Depuey EG et al (2013) Influence of mode of stress and coronary risk factor burden upon long-term mortality following normal stress myocardial perfusion single-photon emission computed tomographic imaging. Am J Cardiol 111:846-850CrossRef
19.
Zurück zum Zitat Nair SU, Ahlberg AW, Katten DM, Heller GV (2015) Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial erfusion imaging? J Nucl Cardiol 22:22-35CrossRef Nair SU, Ahlberg AW, Katten DM, Heller GV (2015) Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial erfusion imaging? J Nucl Cardiol 22:22-35CrossRef
20.
Zurück zum Zitat Poulin M, Alexander S, Doukky R (2016) Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol 23:202-211CrossRef Poulin M, Alexander S, Doukky R (2016) Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol 23:202-211CrossRef
21.
Zurück zum Zitat Rozanski A, Berman D (2020) Optimizing the assessment of patient clinical risk at the time of cardiac stress testing. JACC Cardiovasc Imaging 13:616-623CrossRef Rozanski A, Berman D (2020) Optimizing the assessment of patient clinical risk at the time of cardiac stress testing. JACC Cardiovasc Imaging 13:616-623CrossRef
23.
Zurück zum Zitat Maddahi J, Lazewatsky J, Udelson JE et al (2020) Phase-III clinical trial of fluorine-18 flurpiridaz Positron emission tomography for evaluation of coronary artery disease. J Am Coll Cardiol 76:391-401CrossRef Maddahi J, Lazewatsky J, Udelson JE et al (2020) Phase-III clinical trial of fluorine-18 flurpiridaz Positron emission tomography for evaluation of coronary artery disease. J Am Coll Cardiol 76:391-401CrossRef
24.
Zurück zum Zitat Murthy VL, Naya M, Foster CR et al (2011) Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 124:2215-2224CrossRef Murthy VL, Naya M, Foster CR et al (2011) Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 124:2215-2224CrossRef
25.
Zurück zum Zitat Herzog BA, Husmann L, Valenta I et al (2009) Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150-156CrossRef Herzog BA, Husmann L, Valenta I et al (2009) Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150-156CrossRef
26.
Zurück zum Zitat Patel KK, Spertus JA, Chan PS et al (2020) Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identified patients with a survival benef from revascularization. Eur Heart J 41:759-768CrossRef Patel KK, Spertus JA, Chan PS et al (2020) Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identified patients with a survival benef from revascularization. Eur Heart J 41:759-768CrossRef
27.
Zurück zum Zitat Defina LF, Radford NB, Barlow CE et al (2019) Association of all-cause and cardiovascular mortality with high levels of physical activity and concurrent coronary artery calcification. JAMA Cardiol 4:174-181CrossRef Defina LF, Radford NB, Barlow CE et al (2019) Association of all-cause and cardiovascular mortality with high levels of physical activity and concurrent coronary artery calcification. JAMA Cardiol 4:174-181CrossRef
28.
Zurück zum Zitat Arnson Y, Rozanski A, Gransar H et al (2017) Impact of exercise on the relationship between CAC Scores and all-cause mortality. JACC Cardiovasc Imaging 10:1461-1468CrossRef Arnson Y, Rozanski A, Gransar H et al (2017) Impact of exercise on the relationship between CAC Scores and all-cause mortality. JACC Cardiovasc Imaging 10:1461-1468CrossRef
29.
Zurück zum Zitat Rozanski A, Arnson Y, Gransar H et al (2020) The association between self-reported physical activity, coronary artery calcium scores, and mortality risk among older adults. Mayo Clin Proc Innov Qual Outcomes 4:229-237CrossRef Rozanski A, Arnson Y, Gransar H et al (2020) The association between self-reported physical activity, coronary artery calcium scores, and mortality risk among older adults. Mayo Clin Proc Innov Qual Outcomes 4:229-237CrossRef
Metadaten
Titel
The imperative to assess physical function among all patients undergoing stress myocardial perfusion imaging
verfasst von
Alan Rozanski, MD
Daniel S. Berman, MD
Ami E. Iskandrian, MD, MASNC
Publikationsdatum
18.10.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02378-9

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Erhöhte Hypoglykämie-Gefahr nach Beginn einer Betablockertherapie

Beginnen Diabetiker eine Behandlung mit Betablockern, verdoppelt sich in den ersten Wochen fast das Hypoglykämie-Risiko, normalisiert sich mit der Zeit aber wieder. Besondere Vorsicht ist unter einer Therapie mit nichtselektiven Wirkstoffen geboten.

Podcast

Vom Wert der Ernährung bei neurodegenerativen Erkrankungen

Am Beispiel Parkinson zeigt sich, dass Ernährung nicht nur präventiv förderlich ist, sondern auch die Wirkung von Medikamenten und den Krankheitsverlauf beeinflusst. Prof. Dr. Andrés Ceballos-Baumann, München, fasst die aktuelle Studienlage zusammen, nennt die bestehenden Probleme und veranschaulicht seine Vorgehensweise.

ePA: Entlastung oder Mehrarbeit?

Die elektronische Patientenakte (ePA) soll das Gesundheitswesen revolutionieren. Mit über 2000 Krankenhäusern und mehr als 100.000 ärztlichen Praxen ist sie eines der größten Digitalisierungsprojekte Europas. Während die Politik die ePA als „Gamechanger“ feiert, zeigt sich in der Praxis ein anderes Bild.

Herzkongress ACC 2025: Diese neuen Studien stehen im Brennpunkt

Vom 29. bis 31. März findet in Chicago der Herzkongress ACC 2025 statt. Die Liste der als „Late-breaking Trials“ in den Blickpunkt gerückten neuen Studien zu wichtigen kardiologischen Themen ist wieder einmal lang.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.